Identification of amyloid-beta 1-42 binding protein fragments by screening of a human brain cDNA library

Neuroscience Letters

Volumn 397, Issue 1-2, 2006, Pages 79-82

  Munguia, Maria Elena ^a   Govezensky, Tzipe ^a   Martinez, Rodrigo ^a   Manoutcharian, Karen ^a   Gevorkian, Goar ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Amyloid beta peptide; Human complex I; Mitochondrial dysfunction; Phage displayed cDNA library

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN 1-42; BINDING PROTEIN; COMPLEMENTARY DNA; MITOCHONDRIAL ENZYME; NADH UBIQUINONE OXIDOREDUCTASE CHAIN 3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BRAIN; CARBOXY TERMINAL SEQUENCE; CELL ACTIVITY; DNA ISOLATION; DNA LIBRARY; DNA PURIFICATION; DNA SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; PHAGE DISPLAY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION;

AMYLOID BETA-PROTEIN; BLOTTING, SOUTHERN; BRAIN; DNA FRAGMENTATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE LIBRARY; GENETIC SCREENING; HUMANS; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; PROTEINS;

EID: 33644755673     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.11.061     Document Type: Article

References (36)

1. A.M. Aleardi, G. Benard, O. Augereau, M. Malgat, J.C. Talbot, J.P. Mazat, T. Letellier, J. Dachary-Prigent, G.C. Solain, and R. Rossignol Gradual alteration of mitochondrial structure and function by β-amyloids: importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release J. Bioenerg. Biomembr. 37 2005 207 225
2. C. Behl, J.B. Davis, R. Lesley, and D. Schubert Hydrogen peroxide mediates amyloid beta protein toxicity Cell 77 1994 817 827
3. L.M. Billings, S. Oddo, K.N. Green, J.L. McGaugh, and F.M. LaFerla Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice Neuron 45 2005 675 688
4. J. Busciglio, A. Lorenzo, J. Yeh, and B.A. Yankner Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding Neuron 14 1995 879 888
5. L. Canevari, A.Y. Abramov, and M.R. Duchen Toxicity of amyloid β peptide: tales of calcium, mitochondria, and oxidative stress Neurochem. Res. 29 2004 637 650
6. C.S. Casley, L. Canevari, J.M. Land, J.B. Clark, and M.A. Sharpe β-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities J. Neurochem. 80 2002 91 100
7. C.S. Casley, J.M. Land, M.A. Sharpe, J.B. Clark, M.R. Duchen, and L. Canevari β-Amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons Neurobiol. Dis. 10 2002 258 267
8. B.A. Chromy, R.J. Nowak, M.P. Lambert, K.L. Viola, L. Chang, P.T. Velasko, B.W. Jones, S.J. Fernandez, P.N. Lacor, P. Horowitz, C.E. Finch, G.A. Krafft, and W.L. Klein Self-assembly of Abeta(1-42) into globular neurotoxins Biochemistry 42 2003 12749 12760
9. J. El Khoury, S.E. Hickmann, C.A. Thomas, J.D. Loike, and S.C. Silverstein Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease Neurobiol. Aging 19 1998 S81 S84
10. P. Fernandez-Vizarra, A.P. Fernandez, S. Castro-Blanco, J. Serrano, M.L. Bentura, R. Martinez-Murillo, A. Martinez, and J. Rodrigo Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease Histol. Histopathol. 19 2004 823 844
11. G.K. Gouras, J. Tsai, J. Naslund, B. Vincent, M. Edgar, F. Checler, J.P. Greenfield, V. Haroutunian, J.D. Buxbaum, H. Xu, P. Greengard, and N.R. Relkin Intraneuronal Aβ42 accumulation in numan brain Am. J. Pathol. 156 2000 15 20
12. X.Y. He, H. Schulz, and S.Y. Yang A human brain L-3-hydroxyacyl-coenzyme A dehydrogenase is identical to an amyloid β-peptide-binding protein involved in Alzheimer's disease J. Biol. Chem. 273 1998 10741 10746
13. K. Hensley, J.M. Carney, M.P. Mattson, M. Aksenova, M. Harris, J.F. Wu, R.A. Floyd, and D.A. Butterfield A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 91 1994 3270 3274
14. K. Jacobsson, and L. Frykberg Shotgun phage display cloning Comb. Chem. High Throughput Screen. 4 2001 135 143
15. R. Kayed, E. Headd, J.L. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman, and C.G. Glabe Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 488
16. NTR and activates NFκB in human neuroblastoma cells J. Neurosci. Res. 54 1998 798 804
17. L.F. Lue, D.G. Walker, L. Brachova, T.G. Beach, J. Rogers, A.M. Schmidt, D.M. Stern, and S.D. Yan Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism Exp. Neurol. 171 2001 29 45
18. J.W. Lustbader, M. Cirilli, C. Lin, H.W. Xu, K. Takuma, N. Wang, C. Caspersen, X. Chen, S. Pollak, M. Chaney, F. Trinchese, S. Liu, F. Gunn-Moore, L.F. Lue, D.G. Walker, P. Kuppusamy, Z.L. Zewier, O. Arancio, D. Stern, S.S. Yan, and H. Wu ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease Science 304 2004 448 452
19. D.G. Lynn, and S.C. Meredith Review: model peptides and the physicochemical approach to β-amyloids J. Struct. Biol. 130 2000 153 173
20. K. Manoutcharian, G. Acero, M.E. Munguia, J.A. Montero, T. Govezensky, C. Cao, K. Ugen, and G. Gevorkian Amyloid-beta peptide specific single Caín Fv antibodies isolated from an immune phage display library J. Neuroimmunol. 145 2003 12 17
21. K. Manoutcharian, J. Sotelo, E. Garcia, A. Cano, and G. Gevorkian Characterization of cerebrospinal fluid antibody specificities in neurocysicercosis using phage display peptide library Clin. Immunol. 91 1999 117 121
22. R. McFarland, D.M. Kirby, K.J. Fowler, A. Ohtake, M.T. Ryan, D.J. Amor, J.M. Fletcher, J.W. Dixon, F.A. Collins, D.M. Turnbull, R.W. Taylor, and D.R. Thorburn De novo mutations in the mitochondrial ND3 gene as a cause of infantile mitochondrial encephalopathy and complex I deficiency Ann. Neurol. 55 2003 5 64
23. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, R. Kayed, R. Metherate, M.P. Mattson, Y. Akbari, and F.M. LaFerla Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction Neuron 39 2003 409 421
24. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular Cloning: A Laboratory Manual 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
25. D.J. Selkoe Alzheimer's disease: a central role for amyloid J. Neuropathol. Exp. Neurol. 53 1994 438 447
26. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
27. R.H. Takahashi, T.A. Milner, F. Li, E.E. Nam, M.A. Edgar, H. Yamaguchi, M.F. Beal, H. Xu, P. Greengard, and G.K. Gouras Intraneuronal Alzheimer Aβ42 accumulates in multivesicular bodies and is associated with synaptic pathology Am. J. Pathol. 161 2002 1869 1879
28. K. Takuma, J. Yao, J. Huang, H. Xu, X. Chen, J. Luddy, A.C. Trillat, D.M. Stern, O. Arancio, and S.S. Yan ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction FASEB J. 19 2005 597 598
29. R.W. Taylor, R. Singh-Kler, C.M. Hayes, P.E.M. Smith, and D.M. Turnbull Progressive mitochondrial disease resulting from a novel missense mutation in the mitochondrial DNA ND3 gene Ann. Neurol. 50 2001 104 107
30. D.M. Walsh, I. Klyubin, J.M. Fadeeva, M.J. Rowan, and D.J. Selkoe Amyloid-β oligomers: their production, toxicity and therapeutic inhibition Biochem. Soc. Trans. 30 2002 552 557
31. J.M. van der Walt, K.K. Nicodemus, E.R. Martin, W.K. Scott, M.A. Nance, R.L. Watts, J.P. Hubble, J.L. Haines, W.C. Koller, K. Lyons, R. Pahwa, M.B. Stern, A. Colcher, B.C. Hiner, J. Jankovic, W.G. Ondo, F.H. Allen Jr., C.G. Goetz, G.W. Small, F. Mastaglia, J.M. Stajich, A.C. McLaurin, L.T. Middleton, B.L. Scott, D.E. Schmechel, M.A. Pericak-Vance, and J.M. Vance Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease Am. J. Hum. Genet. 72 2003 804 811
32. H.Y. Wang, D.H.S. Lee, M.R. D'Andrea, P.A. Peterson, and R.P. Shank β-amyloid1-42 binds to α7 nicotinic acetylcholine receptor with high affinity J. Biol. Chem. 275 2000 5626 5632
33. S.D. Yan, J. Fu, C. Soto, X. Chen, H. Zhu, F. Al-Mohanna, K. Collison, A. Zhu, E. Stern, T. Saido, M. Tohyama, S. Ogawa, A. Roher, and D. Stern An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease Nature 389 1997 689 695
34. S.D. Yan, and D.M. Stern Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD) Int. J. Exp. Pathol. 86 2005 161 171
35. S.D. Yan, H. Zhu, J. Fu, S.F. Yan, A. Roher, W.W. Tourtellotte, T. Rajavashisth, X. Chen, G.C. Godman, D. Astern, and A.M. Schmidt Amyloid-β peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 94 1997 5296 5301
36. C. Zhang, M.P. Lambert, C. Bunch, K. Barber, W.S. Wade, G.A. Krafft, and W.L. Klein Focal adhesion kinase expressed by nerve cell lines shows increased tyrosine phosporylation in response to Alzheimer's A beta peptide J. Biol. Chem. 269 1994 25247 25250